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ABSTRACT We have examined the karyological consequences of dihydrofolate reductase
gene amplification in a series of six rat hepatoma cell lines, all derived from the same clone .
Cells of three of these lines express a series of liver-specific functions whereas those of three
others fail to express these functions. Cells of each line have been subjected to stepwise
selection for methotrexate resistance and, in most cases, resistance is associated with a 40-
50-fold amplification of sequences hybridizing to a dihydrofolate reductase cDNA probe . In
one line no modified chromosome is observed, whereas in two others the amplified genes
are associated with an expanded chromosomal region . R-banding analysis of these karyotypes
showed that few changes have occurred. These observations apply to two of the well-
differentiated lines, and to a variant able to revert to the differentiated state. In contrast, in
the two stably dedifferentiated hepatoma cell lines, amplified dihydrofolate reductase genes
are found on large chromosomes of variable size, on ring chromosomes, and on chromosomes
containing terminal, median, or multiple centromeres . We conclude that the nature of the
chromosomal changes associated with dihydrofolate reductase gene amplification are the
result of differences in cell lines rather than in the protocols employed for selection .
Amplified dihydrofolate reductase (DHFR)' genes in mouse,
hamster, and human cells are associated with a wide variety
of karyotypic alterations, including their presence on one or
more chromosomes as an expanded region (2, 3, 12, 26, 27),
their presence in extensively rearranged chromosomes (22,
32), or as extrachromosomal elements or double minute
chromosomes (4, 21). The various configurations ofamplified
sequences may be due to differences in mechanisms under-
lying the amplification process, differences in selection pro-
cedures employed in various laboratories, or to the use of
different cell lines.
To determine whether the nature of chromosomal aberra-
'Abbreviations used in this paper: DHFR, dihydrofolate reductase;
MTX, methotrexate.
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tions associated with DHFR gene amplification is a function
of cell type or of selection protocol, we have studied a set of
sister clones with different phenotypes derived from a clonal,
rat hepatoma cell line. Within this relatively constant genetic
and variable epigenetic background, we have compared the
chromosomal changes that occur during the acquisition of
resistance to methotrexate (MTX) using a single selection
protocol. The cells used include three clones of well-differen-
tiated cells characterized by the expression of a number of
proteins specific to hepatocyte differentiation and three var-
iant clones that are deficient in the expression of hepatocyte
functions (10). We do find a pattern of differences in the
structure of chromosomes with amplified DHFR genes in the
various cell lines, and suggest that the nature of the chromo-
somal aberrations obtained is a function of the phenotype of
the cells.
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FIGURE 1
￿
Genealogy of the rat hepatoma clones and their variants.
On the left are the well-differentiated clones, and on the right are
their variants. The unbroken arrows indicate that the clone is a
direct descendant of the immediate progenitor on the figure, and
the broken arrow signifies that intermediate clones (not shown)
exist. H5 cells arose during an attempt to select H411EC3 cells that
can grow in suspension: after a number of passages the culture
became heterogeneous, and subcloning led to the isolation of H5.
p4 cells appeared in a twice-cloned population of Fu5-5 cells that
had been selected for resistance to eight azaguanine. C2 cells were
observed as a morphologic variant and immediately cloned from a
freshly thawed culture of Fan cells.
MATERIALS AND METHODS
Cell Lines and Culture Conditions:
￿
The six hepatoma clones are
all derivatives of line H411EC3 of Pitot et al. (28), adapted to growth in vitro
from the Reuber H35 hepatoma (29). Their derivation is shown in Fig. 1.
Clones H41I, Fu5-5, and Fao express functions characteristic ofhepatic differ-
entiation, whereas H5, p4, and C2 cells fail to do so (10). Reversion to the
differentiated state has been obtained for derivatives of C2, but not of H5 and
p4 (8, 9 and unpublished results). Cells were grown in modified (7) Ham's F12
medium (20) lacking hypoxanthine and thymidine, supplemented with 5%
fetal calf serum (GIBCO Laboratories, Santa Clara, CA). Although the various
clones used here were isolated at widely different times (10, 28), the cells have
not been in continuous culture. Immediately following the isolation of each
clone, a large number ofampules was frozen. All experiments were undertaken
with freshly unfrozen cells.
Methotrexate Selection:
￿
The same protocol was used for all six
clones. First a series ofpetri dishes was seeded with 1-2.5 x 10' cells/cmZ with
concentrations of MTX of 1-100 nM. This range ofconcentrations bracketed
responses varying from no effect to complete killing ofcells. Dishes with some
surviving cells (in most cases at 20 nM MTX) were allowed to recover by one
or two passages at this MTX concentration, and further selection was pursued
by plating 1-4 x 10' cells/cm' in two- (or four-) fold increments in MTX
concentration. This stepwise process, including two passages of cells at the
given MTX concentration, was continued and cells were finally obtained with
resistance to 2-20 AM MTX. During the courseofthis stepwise selection, MTX
resistant populations were frozen at -80° to permit analysis of the progression
of DHFR enzyme content, DHFR gene copy number, and karyotypic changes.
Stability of MTX Resistance:
￿
l-2 x 105 MTX-resistant cells were
plated into MTX-free medium, and passaged every week at a 1:100 dilution
over 60 cell generations. At 20, 40, and 60 cell generations, the DHFR enzyme
content was determined. At 60 cell doublings in the absence ofMTX, 2 x 105
cells were seeded in medium containing MTX at the concentration to which
cells were resistant when the stability test was started.
Determination of DHFR Enzyme Content: DHFR enzyme
contentwas determined using the stoichiometricbinding of['H]MTX to DHFR
(18). Free ['H]MTX was removed from the bound fraction by the addition of
activated charcoal coated with dextran and bovine serum albumin. Resistant
cells were grown for 72 h in MTX-free medium before assay to free the DHFR
from binding to MTX.
Estimation of DHFR Gene Amplification :
￿
The blot hybridiza-
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tion technique of Gasser et al. (17) was employed. This method allows for a
measure of differential DHFR gene amplification; genomic DNA samples are
hybridizedto botha'ZP-labeled DHFR cDNA clone (6) andto a serum albumin
"P-labeled cDNA (supplied by J. Taylor, Gladstone Research Institute, San
Francisco, CA). The hybridization intensities are compared to densitometric
scanning in a linear response range (see Brown et al. [5]).
Karyotype Analyses:
￿
Karyotypes were performed on colchicine or
colecimide-arrested metaphases by the standard air-drying technique and were
treated for R-binding (l3). Localization ofDHFR genes was determined by in
situ hybridization of iodinated DHFR cDNA as described previously (21 ).
RESULTS
Properties of Methotrexate Resistant Hepatoma
Ce/I Lines
Fig. 1 provides the geneology of the six hepatoma clones.
H4II is the original Reuber H35 clone of Pitot et al. (28) from
which was derived successively Fu5-5 and Fao. H4II gave rise
to the dedifferentiated variant H5, whereas p4 cells derive
from Fu5-5. Dedifferentiated variant FaofI C2 (referred to as .
C2), a descendant of Fao cells, reverts to the differentiated
state at a spontaneous frequency of 10-8 and can be induced
to undergo partial reversion at a frequency of 1-6 X 10-2.
Thus far it has not been possible to obtain revertants of H5
and P4 (see Deschatrette et al. [9] for details).
Cells of all six clones were subjected to the same protocol
of stepwise selection for MTX resistance using twofold or
fourfold increments in drug concentration. Table I gives a
summary ofthe properties of the sensitive linesand the MTX-
resistant populations derived from them. In most cases resist-
ance to 1-2,uM MTX is associated with a 40-50-fold ampli-
fication of the DHFR gene, and a 100-200-fold increase in
the amount of DHFR enzyme activity. Of the six cell lines
only one, H4II, gave rise to resistant cells in the absence of
significant DHFR gene amplification. Similarly, Galivan (16)
selected MTX-resistant Reuber H35 cells (the same cell line
we denote as H4II), and obtained cells with modified MTX
TABLE I
Properties of Sensitive and MTX-resistant Cells
*Specific activity: micromoles DHFR/minutes x 10-'°/milligram of soluble
protein.
' Fold amplification relative to parental cell line.
'Mode and range in parentheses; based upon the analysis of 15-30 meta-
phases.
r The method of detection of amplification level is sufficiently sensitive to
detect an approximately threefold degree of amplification. A threefold
amplification of the DHFR gene cannot be detected by in situ analysis of
metaphase chromosomes employing the method used in this paper.
Cellline
DHFR/mg of
protein*
Amollminlmg
Fold-ampli-
fication of
DHFR
genes=
No. of chromo-
somess
H411 22 1 50(47-57)
H4112 AM MTX 93 (4 x) 31 52 (48-56)
Fu5-5 18 1 52(50-53)
Fu5-5 1 AM MTX 2,400 (1,330) 45 51 (48-54)
Fao 20 1 52(50-55)
Fao 1 AM MTX 2,160 (110 x) 41 50(46-51)
H5 20 1 53 (50-56)
H5 2 pM MTX 3,400 (160 x) 40 51 (45-53)
p4 28 1 46(39-49)
p4 20 AM MTX 2,080 (70 x) 42 46(39-49)
C2 8 1 51 (49-54)
C2 0.2 AM MTX ND 10 52 (50-60)
C2 20 AM MTX 1,140 (140 x) 56 52 (50-53)transport and little or no increase in DHFR enzyme activity .
When we selected the H4II cells for resistance to higherMTX
concentrations (120 AM), a 20-30-fold amplification of the
DHFR gene was obtained, suggesting that mixed modes of
MTX resistance (transport and DHFR gene amplification)
can occur in the same cells . It is surprising and remains
unexplained that only cells of line H4II, the progenitor clone,
fail to undergo DHFR gene amplification at low to interme-
diate MTX concentrations .
The time required to obtain cell populations resistant to 2
AM MTX from the different cell lines differed by a factor of
two (3-7 mo) when the MTX increments were twofold at
each selection step . However, we found in subsequent exper-
iments that when the increments were fourfold or greater, an
obvious difference between cell lines was noted : only dedif-
ferentiated H5 and p4 cells gave resistant progeny readily .
Thus, with some cell lines, attempts to obtain resistance and
gene amplification may fail when the step increments are
large.
Localization ofAmplified Dihydrofolate
Reductase Genes
Karyotype analyses and in situ hybridization to localize the
amplified DHFR genes have been undertaken on each of the
resistant populations . We present here results concerning
intermediate levels of resistance (0.2-40 AM) with the aim of
observing chromosomal changes in the absence of secondary
mutations (superimposition of transport [16, 30] or DHFR
affinity [14, 18]) that may occur in addition to initial gene
amplification events . In no cases were double minute chro-
mosomes observed, and growth of the resistant cells in the
absence of MTX for 60 generations did not result in a
significant reduction in amplified DHFR genes or DHFR
enzyme content (data not shown) .
Fig. 2 shows representative metaphase spreads after hybrid-
ization to a iodinated mouse DHFR cDNA probe (6) . Addi-
tional metaphase spreads showing in situ localization of am-
plified DHFR genes in these cell lines have been published in
a preliminary report (15) . Three classes of labeled chromo-
somes were observed . (a) In Fao cells the majority of cells
(60%) contained a single chromosome carrying DHFR genes.
In spreads where the labeling did not obscure it, this small
chromosome appeared as a metacentric which differed in no
obvious way from the small metacentric chromosomes of
sensitive Fao cells (see Fig. 3) . (b) In Fu5-5 and C2 cells,
DHFR genes were localized to one (90%) or two (10%)
chromosomes that, in comparison with the karyotype of
sensitive Fu5-5 and C2 cells, constituted a new, large, subtel-
ocentric chromosome, whose length increased with higher
levels of resistance (Fig . 26, c) . 3) Strikingly different results
were obtained for H5 and p4 cells, the dedifferentiated, non-
reverting variants. One to two chromosomes per cell (range
one to three) containing DHFR genes were present, but they
were highly variable from one metaphase to another in both
size and structure, containing terminal, median, or multiple
centromeres, or constituting ring structures . Examples of
some of these structures are shown in Fig . 2e-h . The differ-
ences in DHFR containing chromosomes in the different
populations were not paralleled by a significant difference in
DHFR gene copy number (Table I) .
Karyotypes of Sensitive and Methotrexate-
resistant Cells
Metaphases of sensitive and resistant cells were subjected
to thermal denaturation to obtain R-banding (13). Fig . 3
shows karyotypes from sensitive Fao cells, and the resistant
FIGURE 2
￿
In situ hybridization of amplified DHFR genes . (a) Fao, resistant to 1 AM MTX; (b) Fu5-5, resistant to 1 AM MTX ; (c) C2, resistant to 0.2 AM MTX ; (d) C2 resistant to 20 gM MTX (note that the labeled chromosome is markedly longer in d than in c ; (e-g) examples of metaphases of H5 cells resistant to 2 IAM MTX ; (h) p4, resistant to 40 AM MTX .
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499FIGURE 3 R-banded metaphases of Fao cells and of MTX-resistant cells of Fao, Fu5-5, and C2 . Chromosomes are arranged
according to Dev et al . (11) . Some chromosomes are grouped, either when exact identification was not possible (16-18 and 19-
20) or when translocations have occurred between neighbors (3, 4) . U signifies unidentified chromosomes, M, and M z are
frequently encountered marker chromosomes, and the category "New" includes markers found in resistant cells but not in their
sensitive parent. Three types of arrows are used . Thin, black arrows denote the modified copy of chromosome 13 found in both
sensitive and resistant cells, and on the right, the further modified chromosome 13 found in resistant cells . The dotted arrow
shows the modified chromosome 6 containing a typical expanded region, but carrying no DHFR genes . The wide, white arrows
show the chromosome(s) or chromosome group that carries amplified DHFR genes (see Fig . 2) .
cells whose amplified genes are present on identifiable chro-
mosomes, i.e ., Fao, Fu5-5, and C2. Because the sensitive cells
of Fao, Fu-5-5, andC2 show very similar karyotypes, we have
chosen to present a metaphase from Fao, a widely used cell
line, as representative . As can be seen in Fig . 3, in Fao most
chromosomes are present in two or three copies ; no systematic
monosomies are observed . Contrasted to the karyotype of the
Norway rat (11), from which the cell lines were ultimately
derived, complex interchanges between chromosome 3 and 4
500
￿
THE JOURNAL OF CELL BIOLOGY - VOLUME 99, 1984
have occurred, giving rise to copies of chromosome 4 contain-
ing the short arms of chromosome 3, as well as other ex-
changes between the two chromosomes . A modified chro-
mosome 13 (expanded short arms), an unidentified telocen-
tric, and a large submetacentric chromosome (MI), whose
long arms can be identified as chromosome 10 in G-banded
metaphases, are regular features of these lines. In Fig. 3 the
small metacentric chromosomes are grouped by size .
We consider now the karyotypes of resistant Fao, Fu5-5,and C2 cells (Fig. 3). The karyotype of resistant Fao cells is
very similar to that of the sensitive parent; one or two new
subtelocentric chromosomes are observed (probably derived
by the addition of material onto the already modified chro-
mosome 13)-these chromosomes do not contain amplified
DHFR genes. The amplified genes are present on chromo-
somes of the size and shape of pairs 16-18; no obvious
modifications in size or banding patterns of these chromo-
somes can be detected. In Fu5-5 cells, where the amplified
DHFR genes are present in a subtelocentric chromosome
showing expanded, long arms,this new chromosome, lacking
clearly defined bands, as well as newly modified copies of
chromosome 13, can be seen; no other changes are evident.
In C2 cells the DHFR-containing long, subtelocentric chro-
mosome can be identified, as well as blocks of darkly staining
material added onto chromosomes 4, 6, and most likely 13.
The region between the long arms of chromosome 6 and its
newly acquired satellites might be defined as homogeneously
staining region (3); nevertheless, it does not contain amplified
DHFR genes.
The new chromosome containing amplified DHFR genes
in Fu5-5 and C2 cells has short arms compatible with its
origin from one of the chromosomes of group 16-18, where
all ofthe amplified genes are located in Fao cells. A reasonable
interpretation ofthese observations is that the original DHFR
gene is present in one of these chromosomes and that it is
amplified in the absence oftranslocation in each of the three
cell lines. This interpretation cannot be affirmed further, in
that there is no simple method of identifying the chromo-
some(s) carrying the original DHFR genes in each of these
clones. The modified chromosome 13 is further modified in
resistant cells of the three independent lines; this is probably
not a random change.
R-banded metaphases of resistant H5 cells (p4 was not
studied) have proven difficult to interpret in the light of the
results of in situ hybridization, and are not presented here. As
shown in Fig. 2, DHFR containing chromosomes are very
different from one metaphase to another. It is clear that
multiple rearrangements accompany DHFR gene amplifica-
tion in H5 and p4, and only in cellsofthese two variant lines.
In MTX-resistant populations ofboth H5 and p4, a stem cell
failed to emerge.
Expression of Differentiation by Sensitive and
MTX-resistant Cells
An initial purpose of this work was to investigate the
influence of DHFR gene amplification on the expression
of differentiation. This was assessed by three criteria (see
Deschatrette et al . [9] for methods): the production of serum
albumin, activity and inducibility of tyrosine aminotrans-
ferase, and the ability of cells to proliferate in glucose-free
medium, where survival requires activity of liver-specific glu-
coneogenic enzymes (1). Sensitive and MTX-resistant cellsat
various levels of resistance have been studied. Detailed results
will not be presented inasmuch as no qualitative changes were
observed. H41I, Fu5-5, and Fao cells, both sensitive and
resistant, remained clearly positive by all three criteria. In
addition, at all stages of selection they retained the morpho-
logical properties characteristic of well-differentiated hepa-
toma cells. Among the three variant lines only C2 cells were
studied; by all criteria the resistant cellsresembled the sensitive
parental cells.
DISCUSSION
Our results show that the same protocol of MTX selection
results in markedly different chromosome changes in closely
related cell lines with similar numbers of DHFR genes, indi-
cating that the karyological consequences of gene amplifica-
tion are a function of cell type. Several points are worthy of
comment. (a) In resistant Fao, Fu5-5, and C2 cells a single
chromosome, occasionally present in two copies in a cell,
containsthe amplified DHFR genes. These DHFR-containing
chromosomes appear to have all been generated from the
same chromosome, i.e., a small metacentric chromosome,
and they show variable lengths ofthe long (DHFR-containing)
arm. In Fao cells no expansion of the DHFR-containing
chromosome is evident. The degree of expansion of a chro-
mosome is a function of both the gene copy number and the
unit length of amplified DNA sequence, which can vary in
independent cell isolates (26, 27). Thus the lack of expansion
of a chromosome does not necessarily exclude the possibility
ofextensive gene amplification, in this case at least 40 copies
of a gene. (b) In resistant C2 cells, but not in the sensitive
parental cells, a modified chromosome 6 contains a nonband-
ing, expanded region, which does not contain DHFR genes
(see Fig. 3). Thus the presence of an expanded region on a
chromosome does not necessarily localize a potentially am-
plified gene for which selection has been accomplished. (c) In
dedifferentiated H5 and p4 cells, multiple aberrations in
DHFR-containing chromosomes have occurred, which is in
contrast to the uniform chromosomal changes in Fao, Fu5-5,
and C2 cells.
It is not clear why various cell lines derived from the same
cell lineage generate different chromosomal aberrations under
the same selection protocol and with the same number of
amplified DHFR genes. In all of the hepatoma cell lines
employed here, the karyotype is relatively stable, and in all
cases the amplified genes are present on chromosomes. A
stable karyotype and chromosomal localization of amplified
DHFR genes is a phenomenon observed in many cell lines
(3, 12, 26, 27), as well as with other amplified genes (25, 33).
In contrast, cells derived from mouse fibroblasts which char-
acteristically are highly aneuploid contain amplified DHFR
genes as self-replicating, extrachromosomal elements, i.e.,
double minute chromosomes (4, 19, 21). The dedifferentiated
variant hepatoma H5 and p4 cell lines appear to be interme-
diate in terms of chromosomal aberrations associated with
DHFR gene amplification. Thus, although the DHFR genes
are chromosomal, the DHFR-containing chromosomes are
highly aberrant and take a variety of forms. Recent studies
(24) show that when cells are subjected to treatments (such as
hydroxyurea) that inhibit DNA synthesis, cells respond by
overreplication (disproportionate replication) of a portion of
the genome, including DHFR genes, in the same cell cycle.
Upon subsequent MTX selection the DHFR genes are selec-
tively retained in the genome. Thus in order for cells to
survive, a number of recombination-repair events must take
place to maintain a viable genome, some ofwhich may result
in various forms of chromosomal rearrangements. In this
context it is intriguing to note that Loquet and Weibel (23)
have found that H5 cells, contrasted to a Fao-H5 hybrid cell
line, which retains liver-specific functions, are deficient in the
ability to excise DNA damage introduced by alkylating agents.
Whether this repair defect in the H5 cells is related to the
extensive chromosomal aberrations in this cell line awaits
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only the differentiated and the reversion-competent variant
cell lines have minimal chromosomal aberrations associated
with DHFR gene amplification is that cells in the differen-
tiated state cannot tolerate extensive chromosomal rearrange-
ments and/or a high degree of alterations in gene dosage of
DNA sequences co-amplified with DHFR genes.
These Reuber H35-derived cell lines show a number of
properties that are associated with retention of the differen-
tiated state and change with its loss. The differentiation state
extends not only to the synthesis of hepatocyte-specific pro-
teins, but also to cell morphology, and even to chromatin
repeat length (31). The results reported here extend these
observations to a new feature, the manner in which cells
respond to environmental stress by remodeling their kary-
otypes. Thus, we have observed that differentiated hepatoma
cellsbecome resistant to MTX either by some change different
from DHFR gene amplification (8411), or they do undergo
DHFR gene ampification, but with a minimum ofkaryotypic
changes (Fao and Fu5-5). Only one variant dedifferentiated
line shows the same pattern of karyotypic changes as the
differentiated cells, and this is the only variant of the three
tested that retains the capacity to revert to the differentiated
state. From these four cases we observe a pattern: resistance
to MTX is associated with little change in karyotype and with
retention of the original phenotype. In contrast, only the
variant lines H5 and p4 showed the kind of karyotypic re-
shuffling that we had anticipated might be incompatible with
retention of the differentiated state.
We thank Evelyne Shechter for excellent technical assistance.
The laboratory of Dr. Weiss was supported by grants from IN-
SERM (PRC), the CNRS (ATP), and the Ministère de la Recherche
et de la Technologie. This project was supported by NATO Research
Grant RG25880. RTS received support from a grant from the Na-
tional Institute ofGeneral Medical Studies (GM-14931).
Receivedfor publication 10 November 1983, and in revisedform 15
,Warch 1984.
REFERENCES
I. Bertolotti, R. 1977. A selective system for hepatoma cells producing glyconeogenic
enzymes. Somatic Cell Genet. 3:365-380.
2. Biedler, J. L., P. W. Melera, and B. A. Spengler. 1980. Specifically altered metaphase
chromosomes in antifolate-resistant Chinese hamster cells that overproduce dihydrofo-
late reductase. Cancer Genet. Cytogenet. 2:47-60.
3. Biedler, J. L., and B. A. Spengler. 1976. A novel chromosome abnormality in human
neuroblastoma and antifolate-resistant Chinese hamster cell lines in culture. J. Nail.
CancerInst. 57:683-695.
4. Brown, P. C., S. M. Beverley, and R. T. Schimke. 1981 . Relationshi p of amplified
dihydrofolate reductase genes to double minute chromosomes in unstably resistant
mouse fibroblast cell lines. Mot. Cell. Biol. 1 :1077-1083.
5. Brown, P. C., T. D. Tlsty, and R. T. Schimke. 1983. Enhancement of methotrexate
resistance and dihydrofolate reductase gene amplification by treatment of mouse 3T6
cells with hydroxyurea . Mot. Cell. Biol. 3:1097-1107.
502
￿
THE JOURNAL OF CELL BIOLOGY - VOLUME 99, 1984
6. Chang, A. C. Y., 1. H. Nunberg, R. J. Kaufman, H. A. Erlich, R. T. Schimke, and S.
N. Cohen. 1978. Phenotypic expression in E. coli ofa DNA sequence coding for mouse
dihydrofolate reductase . Nature(Lond). 275:617-624.
7. Coon, H. G., and M. C. Weiss. 1969. A quantitative comparison of formation of
spontaneous and virus-produced viable hybrids. Proc. Nail. Acad. So. USA. 62:852-
859.
8. Deschatrette, J. 1980. Dedifferentiated variants of a rat hepatoma: partial reversion
induced by cell aggregation . Cell. 22:501-511.
9. Deschatrette, 1., E. E. Moore, M. J. Dubois, and M. C. Weiss. 1980. Dedifferentiated
variants ofa rat hepatoma: reversion analysis. Cell. 19:1043-1051.
10. Deschatrette, J., and M. C. Weiss. 1974. Characterization of differentiated and dediffer-
entiated clones from a rat hepatoma. Biochinrie (Paris). 56:1603-1611.
11. Dev, V. G., and Committee Members. 1973. Standard karyotype of the Norway rat,
Ratlus norvegicus. Cytogenet. Cell Genet. 12:199-205.
12. Dolnick, B. J., R. J. Berenson, J. R. Bertino, R. J. Kaufman, 1. H. Nunberg, and R. T.
Schimke. 1979. Correlation ofdihydrofolate reductase elevation withgene amplification
in a homogeneously stainingchromosomal region in L5178Y cells. J. Cell Biol. 83:394-
402.
13. Dutrillaux, R., andJ. Lejeune. 1971 . Sur one nouvelletechniqued'analyzeducaryotype
humain. C. R. Hebd. ScéancesAcad. Sci. Ser. D Sci. Nat. 272:2638-2640.
14. Flintoff, W. F., S. V. Davidson, and L. Siminovitch . 1976. Isolation and partial
characterization ofthree methotrexate-resistant phenotypes from Chinesehamsterovary
cells. Somatic Cell Genet. 2:245-261 .
15. Fougere-Deschatrette, C., R. T. Schimke, D. Weil, and M. C. Weiss. 1982. Amplificatio n
of the dihydrofolate reductase gene in rat hepatoma cells and their dedifferentiated
variants. In GeneAmplification. R. T. Schimke, editor. Cold Spring Harbor Press, Cold
Spring Haber, NY. 29-31.
16. Galivan, J. 1979. Transport and metabolism of methotrexate in normal and resistant
cultured rat hepatoma cells. Cancer Res. 39:735-743.
17. Gasser, C. S., C. C. Simonsen, J. W. Schilling, and R. T. Schimke. 1982. Expressio n of
abbreviated mouse dihydrofolate reductase genes in cultured hamster cells. Proc. Nail.
Acad. Sci. USA. 79:6522-6526.
18. Haber, D. A., S. M. Beverley, M. L. Kiely, and R. T. Schimke. 1981 . Properties of an
altered dihydrofolate reductase encoded byamplifiedgenesin cultured mouse fibroblasts .
J. Biol. Chem. 256:9501-95 10.
19. Haber, D. A., and R. T. Schimke. 1981. Unstable amplification of an altered dihydro-
folate reductase gene associated with double-minute chromosomes. Cell. 26:355-362.
20. Ham, R. G. 1965. Clonal growth ofmammalian cells in a chemically defined, synthetic
medium. Proc. Nail. Acad. Sci. USA. 53:288-293.
21 . Kaufman, R. J., P. C. Brown, and R. T. Schimke. 1979. Amplified dihydrofolate
reductase genes in unstably methotrexate-resistant cells are associated with double-
minute chromosomes. Proc. Nat/. Acad. Sci. USA. 76:5669-5673.
22. Kaufman, R. J., S. A. Latt, and P. A. Sharp. 1982. Expressio n and amplification of
DNA introduced intomammalian cells. In Gene Amplification. R. T. Schimke, editor.
Cold Spring Harbor Press, Cold Spring Harbor, NY. 245-250.
23. Loquet, C., and F. J. Weibel. 1982. Geno- and cytotoxicity ofnitrosamine, aflatozin BI
and benzo-a-pyrenein continuous cultures ofrat hepatomacells. Carcinogenesis. 3:213-
218.
24. Mariani, B. D., and R. T. Schimke. 1984. Gene amplification in a single cell cycle in
Chinesehamster ovary cells. J. Biol. Chem. 259:1901-1910.
25. Melton, D. W., J. Brennand, D. H. Ledbetter, D. S. Konecki, A. C. Chinault, and C. T.
Caskey. 1982. Phenotypic reversion at the HPRT locus as a consequence of gene
amplification. In Gene Amplification. R. T. Schimke, editor. Cold Spring Harbor Press,
Cold Spring Harbor, NY. 59-65.
26. Milbrandt, J. D., N. H. Heintz, W. C. White, S. M. Rothman, and J. L. Hamlin. 1981.
Methotrexate-resistan t Chinese hamster ovary cells have amplified a 135-kilobase-pair
region that includes the dihydrofolate reductase gene. Proc. Nall. Acad. Sci. USA.
78:6043-6047.
27. Nunberg, J. N., R. J. Kaufman, R. T. Schimke, G. Urlaub, and L. A. Chasin. 1978.
Amplified dihydrofolate reductase genes are localized to a homogeneously staining
region of a single chromosome in a methotrexate resistant Chinese hamster ovary cell
line. Proc. Nail. Acad. Sci. USA. 75:5553-5556.
28. Pitot, H. C., C. Peraino, P. A. Morse, and V. A. Potter. 1964. Hepatoma in tissue
culture compared with adapting liver in vivo. Nail. Cancer Inst. Monogr. 13:229-242.
29. Reuber, M. D. 1961. A transplantable bile secretinghepatocellularcarcinoma in the rat.
J. Nat/. Cancer Inst. 26:891-899.
30. Sirotnak, F. M., D. M. Moccio, L. E. Kelleher, and L. J. Goutas, 1981 . Relative
frequency and kinetic propertiesoftransport-defective phenotypesamong methotrexate-
resistant L1210 elonal cell lines derived in vivo. Cancer Res. 41:4447-4452.
31 . Sperling, L., and M. C. Weiss. 1980. Chromatin repeatlength correlated with phenotypic
expression in hepatoma cells, their dedifferentiated variants and somatic hybrids. Proc.
Nail. Acad. Sci. USA. 77:3412-3416.
32. Tyler-Smith, C., and C. J . Bestock. 1981. Gene amplification in methotrexate-resistant
mouse cells. 11. Rearrangements and amplification ofnon-dihydrofolate reductase gene
sequencesaccompany chromosomal changes. J. Mot. Biol. 153:219-236.
33. Wahl, G. M., V. Allen, S. Delbruck, W. Eckhart, J. Meinkoth, R. Padgett, B. R. de
Saint Vincent, J. Rubnitz, G. Stark, and L. Vitto. 1982. Analysis of CAD gene
amplification using molecular cloning, gene transfer, and cytogenetics. In Gene Ampli-
fication. R. T. Schimke, editor. Cold Spring Harbor Press. Cold Spring Harbor, NY.
167-175.